If you are in distress or in crisis, please reach out to a clinician or a local helpline before considering any pharmacological information on this page. In the US: 988 Suicide & Crisis Lifeline. In the UK: Samaritans 116 123. Internationally: findahelpline.com.
Addiction & cravings
Emerging observational signal that GLP-1 agonists reduce craving behaviour. Treat as exploratory.
Why certain peptides surface — weighted by clinical relevance.
Appetite & food-noise suppression
weight 0.90GLP-1 / incretin signal on craving behaviour — observational, exploratory.
Mood regulation
weight 0.40Reward-pathway overlap; secondary mood / impulse effect.
Outcome × ingredient signal — backed by indexed studies.
Each cell shows the clinical signal status and the count of indexed studies for that ingredient × outcome pair. Click any cell to open the ingredient brief.
| Outcome \ Ingredient | Semaglutide | Tirzepatide | Retatrutide | Cagrilintide | Semax | Selank |
|---|---|---|---|---|---|---|
| Appetite & food-noise suppression | ·— | ·— | ·— | ·— | — | — |
| Mood regulation | — | — | — | — | ·— | ·— |
Matched protocol templates for this condition.
Matching templates…
What cohorts have used — and at what tier of evidence.
Suggestive, never prescriptive. Mydosage does not recommend a dose, a substance or a protocol. Decisions belong with you and a clinician.